Francis Johnson

Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms

Jie Lu, John S. Kovach, Francis Johnson et al. · Proceedings of the National Academy of Sciences · 2009 · 161 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial

Vincent Chung, Aaron S. Mansfield, Fadi Braiteh et al. · Clinical Cancer Research · 2016 · 126 citations

Pharmacy, Oncology, Pharmacology +9

Reporter gene assay for fish-killing activity produced by Pfiesteria piscicida.

Elizabeth R. Fairey, J S Edmunds, Nora J. Deamer-Melia et al. · Environmental Health Perspectives · 1999 · 57 citations · Full text

Veterinary Medicine, Toxicology, Aquatic Toxicology +13

The novel phospho‐non‐steroidal anti‐inflammatory drugs, OXT‐328, MDC‐22 and MDC‐917, inhibit adjuvant‐induced arthritis in rats

Liqun Huang, GG Mackenzie, Nengtai Ouyang et al. · British Journal of Pharmacology · 2010 · 56 citations · Full text

Medicine, Immunology, Pharmacology +17

Phospho-Sulindac (OXT-328), a Novel Sulindac Derivative, Is Safe and Effective in Colon Cancer Prevention in Mice

Gerardo G. Mackenzie, Yu Sun, Liqun Huang et al. · Gastroenterology · 2010 · 56 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6